Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 18
1990 73
1991 124
1992 99
1993 79
1994 93
1995 116
1996 112
1997 142
1998 140
1999 167
2000 178
2001 167
2002 147
2003 167
2004 176
2005 189
2006 228
2007 248
2008 315
2009 493
2010 594
2011 687
2012 869
2013 951
2014 998
2015 1036
2016 1023
2017 951
2018 851
2019 954
2020 901
2021 816
2022 794
2023 748
2024 320

Text availability

Article attribute

Article type

Publication date

Search Results

14,173 results

Results by year

Filters applied: . Clear all
Page 1
RAS-targeted therapies: is the undruggable drugged?
Moore AR, Rosenberg SC, McCormick F, Malek S. Moore AR, et al. Nat Rev Drug Discov. 2020 Aug;19(8):533-552. doi: 10.1038/s41573-020-0068-6. Epub 2020 Jun 11. Nat Rev Drug Discov. 2020. PMID: 32528145 Free PMC article. Review.
The Frequency of Ras Mutations in Cancer.
Prior IA, Hood FE, Hartley JL. Prior IA, et al. Cancer Res. 2020 Jul 15;80(14):2969-2974. doi: 10.1158/0008-5472.CAN-19-3682. Epub 2020 Mar 24. Cancer Res. 2020. PMID: 32209560 Free PMC article. Review.
Cancer vaccines: Targeting KRAS-driven cancers.
Zhang Y, Ma JA, Zhang HX, Jiang YN, Luo WH. Zhang Y, et al. Expert Rev Vaccines. 2020 Feb;19(2):163-173. doi: 10.1080/14760584.2020.1733420. Epub 2020 Mar 14. Expert Rev Vaccines. 2020. PMID: 32174221 Review.
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Chen S, Vedula RS, Cuevas-Navarro A, Lu B, Hogg SJ, Wang E, Benbarche S, Knorr K, Kim WJ, Stanley RF, Cho H, Erickson C, Singer M, Cui D, Tittley S, Durham BH, Pavletich TS, Fiala E, Walsh MF, Inoue D, Monette S, Taylor J, Rosen N, McCormick F, Lindsley RC, Castel P, Abdel-Wahab O. Chen S, et al. Cancer Discov. 2022 Oct 5;12(10):2434-2453. doi: 10.1158/2159-8290.CD-21-1631. Cancer Discov. 2022. PMID: 35904492 Free PMC article.
Drugging RAS: Moving Beyond KRASG12C.
[No authors listed] [No authors listed] Cancer Discov. 2023 Dec 12;13(12):OF7. doi: 10.1158/2159-8290.CD-ND2023-0010. Cancer Discov. 2023. PMID: 37871268
Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells.
Dost AFM, Moye AL, Vedaie M, Tran LM, Fung E, Heinze D, Villacorta-Martin C, Huang J, Hekman R, Kwan JH, Blum BC, Louie SM, Rowbotham SP, Sainz de Aja J, Piper ME, Bhetariya PJ, Bronson RT, Emili A, Mostoslavsky G, Fishbein GA, Wallace WD, Krysan K, Dubinett SM, Yanagawa J, Kotton DN, Kim CF. Dost AFM, et al. Cell Stem Cell. 2020 Oct 1;27(4):663-678.e8. doi: 10.1016/j.stem.2020.07.022. Epub 2020 Sep 4. Cell Stem Cell. 2020. PMID: 32891189 Free PMC article.
14,173 results
You have reached the last available page of results. Please see the User Guide for more information.